Regulatory Landscape for Medical AI: FDA, CE Marking, and Ukrainian MHSU

Key Points

• The study aims to analyze the regulatory environment for medical AI technologies, focusing on the roles of the FDA, CE marking, and Ukrainian MHSU.
• Conducted a comprehensive review of regulatory documents
• Analyzed compliance requirements of FDA and CE marking
• Examined Ukrainian MHSU regulations related to medical AI
• Identified key similarities and differences in regulatory approaches across regions
• Revealed challenges faced by companies in navigating these regulations
• Suggested potential pathways for harmonizing standards internationally